Genicular Artery Embolization (GAE): A Minimally Invasive Alternative to Knee Replacement

For millions of people suffering from chronic knee pain due to osteoarthritis, the treatment spectrum has long been limited. Patients often start with conservative measures like physical therapy and anti-inflammatory medications, and if those fail, the next—and often daunting—option is total knee replacement surgery. However, a groundbreaking minimally invasive procedure known as genicular artery embolization (GAE) is rapidly emerging as a powerful middle-ground solution. Recent research from the University of Colorado Anschutz School of Medicine highlights how GAE is helping patients find substantial relief and return to the activities they love without undergoing major surgery.

What is Genicular Artery Embolization?

GAE is an outpatient procedure designed to treat chronic knee pain by targeting the source of inflammation at its root. The procedure works by reducing blood flow to abnormal blood vessels within the knee joint that are associated with osteoarthritis-related inflammation. By embolizing—or blocking—these specific vessels, GAE can decrease swelling and discomfort, offering a new lease on life for those who have not responded to conventional treatments.

Dr. Leigh Casadaban, an assistant professor of radiology at the University of Colorado Anschutz School of Medicine and a vascular interventional radiologist who performs the procedure, explains the critical gap GAE fills. “For treating osteoarthritis in the knees, we often think of medications, physical therapy, maybe a steroid injection, and then on the far end of the spectrum is a total knee replacement. There really hasn't been anything for patients in between,” Dr. Casadaban states. “GAE is a promising minimally invasive procedure that may fill that spot for people who have failed conservative treatments but are not yet ready to have a major surgery.”

How the Procedure Works

The GAE procedure is performed under conscious sedation and typically takes between one and two hours. During the treatment, the interventional radiology team makes a small incision near the crease of the leg. Using advanced X-ray imaging and contrast dye for guidance, they navigate a tiny catheter through the femoral artery and into the genicular arteries surrounding the knee. Once the catheter is precisely positioned, microscopic beads are released to block blood flow to the abnormal vessels responsible for the patient's pain.

Patients are monitored for a few hours post-procedure and are usually able to return home the same day. Recovery is generally mild, with doctors advising patients to take it easy for several days. This quick recovery time stands in stark contrast to the lengthy rehabilitation associated with knee replacement surgery.

Patient Experience and Outcomes

The real-world impact of GAE is best illustrated through patient experiences. Cynthia Schraf-Fletcher, a 74-year-old patient, describes her results as “remarkably” successful. Nearly a year after receiving GAE on her right knee, she reports an improvement comparable to the total knee replacement she had on her left knee. “I couldn't be more pleased,” says Schraf-Fletcher, who now finds everyday activities like gardening and riding a stationary bicycle far more enjoyable thanks to the significant reduction in pain.

According to Dr. Casadaban, individuals with mild to moderate osteoarthritis tend to see the most benefit. While patients with more advanced disease can also undergo the procedure, the effects may be less durable. “We find about 70% of patients have phenomenal results. They cut their pain scores in half, sometimes more. We have a few patients with no pain at all after the procedure,” Dr. Casadaban notes. This high success rate offers hope to those who have tried numerous other treatments without finding significant relief.

Long-Lasting Pain Relief

Early and ongoing research continues to produce encouraging data regarding the longevity of pain relief from GAE. The foundational theory is that by reducing inflammation within the knee joint, symptom relief can last for years. This is supported by clinical data. “Four-year data published in Japan shows that if you have one outpatient procedure, your pain relief can last for those four years. In the U.S., we now have two-year data, which shows that if you have a good response, pain relief can last two years. That really speaks to the theory that we're hopefully modifying something in the joint,” explains Dr. Casadaban.

This potential for durable relief is a game-changer. It suggests that GAE is more than a temporary fix; it may actually alter the inflammatory processes within the joint, providing a lasting improvement in quality of life.

The Future of GAE

Originally developed in Japan just over a decade ago, GAE has steadily gained global traction. In the United States, the FDA has granted “breakthrough device status” to several devices related to the procedure since 2021, signaling its potential importance in patient care. Dr. Casadaban is currently leading two clinical trials at CU Anschutz to further explore the procedure's efficacy. One study is examining changes in knee fluid among patients receiving GAE, while another is evaluating a temporary arterial treatment device called Nexsphere-F, designed to block small blood vessels and combat inflammation.

Looking forward, the applications of embolization therapy may extend beyond the knee. Researchers and physicians are beginning to explore its use for other painful musculoskeletal disorders, including frozen shoulder, tennis elbow, and plantar fasciitis. This could open up new avenues for treating a variety of chronic pain conditions with minimally invasive techniques.

For individuals grappling with chronic knee pain and the prospect of major surgery, genicular artery embolization represents a significant step forward. It offers a safe, effective, and minimally invasive path back to an active life, turning the hope of pain-free movement into a tangible reality.